Lucy Therapeutics Secures New Funding to Advance New Alzheimer’s and Parkinson’s Treatments
Lucy Therapeutics, Inc. announced they raised $12.5 million in additional funding led by existing and new investors. The company is working to develop novel therapies based on mitochondrial small-molecule treatments…
Vaxess Technologies announced they raised $12 million in funding. The Cambridge based company is developing a shelf-stable MIMIX skin patch for vaccines and therapeutics. The new funding will continue to…
Nanopath Receives $4 Million in Grants from National Institutes of Health and National Science Foundation
Nanopath announced it received $4 million in funding – a $3 million grant from the NIH and a $1 million grant from the National Science Foundation. The molecular diagnostics company…
Adaptilens, Inc., a pre-clinical company dedicated to transforming the standard of care for cataract surgery, today announced the closing of a Series A financing round of $17.5 million led by Perceptive Xontogeny…
